Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aclaris Therapeutics, Inc. - Common Stock (NQ: ACRS ) 2.900 +0.010 (+0.35%) Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 499,772 Open 2.960 Bid (Size) 2.800 (52) Ask (Size) 2.980 (6) Prev. Close 2.890 Today's Range 2.840 - 2.965 52wk Range 0.8555 - 5.170 Shares Outstanding 71,430,942 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy December 23, 2024 HC Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy with a $20 price target. Aclaris gains after licensing agreement with Biosion for potential best-in-class therapies for atopic dermatitis and... Via Benzinga Santa Rally, January Effect, And Top Stock Picks December 23, 2024 Explore December 23's top pre-market picks, macro insights, and Santa Rally opportunities with StoryTrading's 4-pillar strategy. Join the community for exclusive trade ideas! Via Talk Markets Topics Stocks / Equities Performance YTD +176.19% +176.19% 1 Month -27.32% -27.32% 3 Month +158.93% +158.93% 6 Month +160.09% +160.09% 1 Year +176.19% +176.19% More News Read More This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday December 23, 2024 Via Benzinga Level Up Your Trading: Inside The 4-Pillar Strategy Behind Triple-Digit Returns December 18, 2024 Via Talk Markets Topics Stocks / Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 19, 2024 Via Benzinga Aclaris Therapeutics: Q4 Earnings Insights February 27, 2024 Via Benzinga The Analyst Landscape: 4 Takes On Aclaris Therapeutics January 11, 2024 Via Benzinga Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments November 19, 2024 Via Benzinga War, Gold, And Opportunity: Uncovering Today’s Market Moves November 19, 2024 Via Talk Markets This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday November 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session October 25, 2024 Via Benzinga Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying July 23, 2024 Via Benzinga 3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices July 11, 2024 Via MarketBeat Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying July 08, 2024 Via Benzinga $1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 24, 2024 Via Benzinga ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Biotech’s Role in Addressing the Pancreatic Cancer Emergency March 14, 2024 Via FinancialNewsMedia Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying March 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades January 22, 2024 Via Benzinga Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 22, 2024 Via Benzinga Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket January 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 16, 2024 Via Benzinga Why Is Dermatology Focused Aclaris Therapeutics Stock Trading Higher Today? January 16, 2024 Via Benzinga Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
